Andrew J. DSilva's most recent trade in OptimizeRx Corp was a trade of 703 Common Stock done at an average price of $13.5 . Disclosure was reported to the exchange on Dec. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.51 per share. | 19 Dec 2025 | 703 | 44,735 (0%) | 0% | 13.5 | 9,498 | Common Stock |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.03 per share. | 11 Dec 2025 | 868 | 45,438 (0%) | 0% | 14.0 | 12,178 | Common Stock |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.75 per share. | 01 Oct 2025 | 794 | 46,306 (0%) | 0% | 18.8 | 14,888 | Common Stock |
| OptimizeRx Corp | Andrew J. DSilva | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.98 per share. | 01 Oct 2025 | 414 | 47,100 (0%) | 0% | 19.0 | 7,858 | Common Stock |